Comparison of common acute respiratory infection case definitions for identification of hospitalized influenza cases at a population-based surveillance site in Egypt.


Journal

PloS one
ISSN: 1932-6203
Titre abrégé: PLoS One
Pays: United States
ID NLM: 101285081

Informations de publication

Date de publication:
2021
Historique:
received: 05 06 2020
accepted: 02 03 2021
entrez: 25 3 2021
pubmed: 26 3 2021
medline: 12 10 2021
Statut: epublish

Résumé

Multiple case definitions are used to identify hospitalized patients with community-acquired acute respiratory infections (ARI). We evaluated several commonly used hospitalized ARI case definitions to identify influenza cases. The study included all patients from a population-based surveillance site in Damanhour, Egypt hospitalized for a broad set of criteria consistent with community acquired ARIs. Naso- and oropharyngeal (NP/OP) swabs were tested for influenza using RT-PCR. Sensitivity, specificity and PPV for influenza identification was compared between the 2014 WHO Severe Acute Respiratory Infection (SARI) definition (fever ≥38°C and cough with onset within 10 days), the 2011 WHO SARI definition (fever ≥38°C and cough with onset within 7 days), the 2006 PAHO SARI definition, the International Emerging Infections Program (IEIP) pneumonia case definition, and the International Management of Childhood Illness (IMCI) case definitions for moderate and severe pneumonia. From June 2009-December 2012, 5768 NP/OP swabs were obtained from 6113 hospitalized ARI patients; 799 (13.9%) were influenza positive. The 2014 WHO SARI case definition captured the greatest number of ARI patients, influenza positive patients and ARI deaths compared to the other case definitions examined. Sensitivity for influenza detection was highest for the 2014 WHO SARI definition with 88.6%, compared to the 2011 WHO SARI (78.2%) the 2006 PAHO SARI (15.8%) the IEIP pneumonia (61.0%) and the IMCI moderate and severe pneumonia (33.8% and 38.9%) case definitions (IMCI applies to <5 only). Our results support use of the 2014 WHO SARI definition for identifying influenza positive hospitalized SARI cases as it captures the highest proportion of ARI deaths and influenza positive cases. Routine use of this case definition for hospital-based surveillance will provide a solid, globally comparable foundation on which to build needed response efforts for novel pandemic viruses.

Sections du résumé

BACKGROUND
Multiple case definitions are used to identify hospitalized patients with community-acquired acute respiratory infections (ARI). We evaluated several commonly used hospitalized ARI case definitions to identify influenza cases.
METHODS
The study included all patients from a population-based surveillance site in Damanhour, Egypt hospitalized for a broad set of criteria consistent with community acquired ARIs. Naso- and oropharyngeal (NP/OP) swabs were tested for influenza using RT-PCR. Sensitivity, specificity and PPV for influenza identification was compared between the 2014 WHO Severe Acute Respiratory Infection (SARI) definition (fever ≥38°C and cough with onset within 10 days), the 2011 WHO SARI definition (fever ≥38°C and cough with onset within 7 days), the 2006 PAHO SARI definition, the International Emerging Infections Program (IEIP) pneumonia case definition, and the International Management of Childhood Illness (IMCI) case definitions for moderate and severe pneumonia.
RESULTS
From June 2009-December 2012, 5768 NP/OP swabs were obtained from 6113 hospitalized ARI patients; 799 (13.9%) were influenza positive. The 2014 WHO SARI case definition captured the greatest number of ARI patients, influenza positive patients and ARI deaths compared to the other case definitions examined. Sensitivity for influenza detection was highest for the 2014 WHO SARI definition with 88.6%, compared to the 2011 WHO SARI (78.2%) the 2006 PAHO SARI (15.8%) the IEIP pneumonia (61.0%) and the IMCI moderate and severe pneumonia (33.8% and 38.9%) case definitions (IMCI applies to <5 only).
CONCLUSIONS
Our results support use of the 2014 WHO SARI definition for identifying influenza positive hospitalized SARI cases as it captures the highest proportion of ARI deaths and influenza positive cases. Routine use of this case definition for hospital-based surveillance will provide a solid, globally comparable foundation on which to build needed response efforts for novel pandemic viruses.

Identifiants

pubmed: 33765010
doi: 10.1371/journal.pone.0248563
pii: PONE-D-20-15048
pmc: PMC7993808
doi:

Types de publication

Journal Article Research Support, U.S. Gov't, Non-P.H.S. Research Support, U.S. Gov't, P.H.S.

Langues

eng

Sous-ensembles de citation

IM

Pagination

e0248563

Subventions

Organisme : World Health Organization
ID : 001
Pays : International

Déclaration de conflit d'intérêts

The authors have declared that no competing interests exist.

Références

J Infect Dis. 2013 Dec 15;208 Suppl 3:S189-96
pubmed: 24265478
Arch Intern Med. 2000 Nov 27;160(21):3243-7
pubmed: 11088084
Lancet. 2018 Mar 31;391(10127):1285-1300
pubmed: 29248255
Proc Natl Acad Sci U S A. 2020 Apr 21;117(16):9122-9126
pubmed: 32245814
Lancet Infect Dis. 2002 Jan;2(1):25-32
pubmed: 11892493
Bull World Health Organ. 2018 Feb 1;96(2):122-128
pubmed: 29403115
Infect Control Hosp Epidemiol. 2008 Oct;29(10):921-6
pubmed: 18754739
J Infect Dis. 2013 Apr 15;207(8):1281-5
pubmed: 23382573
Clin Infect Dis. 2000 Nov;31(5):1166-9
pubmed: 11073747
Virol J. 2012 Oct 27;9:247
pubmed: 23102237
J Paediatr Child Health. 2000 Aug;36(4):332-5
pubmed: 10940165
Epidemiol Infect. 2013 Jan;141(1):212-22
pubmed: 22417876
Emerg Infect Dis. 2009 Aug;15(8):1271-8
pubmed: 19751590
J Pediatr. 1989 Sep;115(3):351-6
pubmed: 2549231
Rev Soc Bras Med Trop. 2011 Jul-Aug;44(4):405-11
pubmed: 21789355
Influenza Other Respir Viruses. 2017 Jan;11(1):23-32
pubmed: 27458989
J Infect Dis. 2013 Dec 15;208 Suppl 3:S167-72
pubmed: 24265474
Clin Infect Dis. 2006 Sep 1;43(5):564-8
pubmed: 16886147

Auteurs

Emily Rowlinson (E)

U.S. Naval Medical Research Unit-3, Cairo, Egypt.

Lisa Peters (L)

U.S. Naval Medical Research Unit-3, Cairo, Egypt.

Adel Mansour (A)

U.S. Naval Medical Research Unit-3, Cairo, Egypt.

Hoda Mansour (H)

U.S. Naval Medical Research Unit-3, Cairo, Egypt.

Nahed Azazzy (N)

Egyptian Ministry of Health and Population, Cairo, Egypt.

Mayar Said (M)

U.S. Naval Medical Research Unit-3, Cairo, Egypt.

Sahar Samy (S)

Egyptian Ministry of Health and Population, Cairo, Egypt.

Eman Abbas (E)

Egyptian Ministry of Health and Population, Cairo, Egypt.

Hanaa Abu Elsood (H)

Egyptian Ministry of Health and Population, Cairo, Egypt.

Manal Fahim (M)

Egyptian Ministry of Health and Population, Cairo, Egypt.

Alaa Eid (A)

Egyptian Ministry of Health and Population, Cairo, Egypt.

Erik Reaves (E)

U.S. Centers for Disease Control and Prevention, Atlanta, Georgia, United States of America.

Chris Van Beneden (C)

U.S. Centers for Disease Control and Prevention, Atlanta, Georgia, United States of America.

Sarah Hamid (S)

U.S. Naval Medical Research Unit-3, Cairo, Egypt.

Sonja Olsen (S)

U.S. Centers for Disease Control and Prevention, Atlanta, Georgia, United States of America.

Julia Fitzner (J)

World Health Organization, Geneva, Switzerland.

Erica Dueger (E)

U.S. Naval Medical Research Unit-3, Cairo, Egypt.
U.S. Centers for Disease Control and Prevention, Atlanta, Georgia, United States of America.
Sanofi Pasteur, Medical Evidence Generation, Lyon, France.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH